CDKN2A and glioblastoma: On multivariable CPH analysis incorporating significant clinical variables, CDKN2A/B loss was the only genetic co-alteration that remained significantly associated with worse OS in NF1-mutant glioblastoma (Figure 1F and Supplemental Table 4).